MTOR and nonpapillary renal cell carcinoma: Moreover, circPTEN suppresses ccRCC progression and resistance to mTOR inhibitors by enhancing PTEN expression through reduced methylation of the PTEN promoter and decreasing GLUT1 expression by lowering its m6A methylation (Zhan et al., 2023).